More Sunshine Linked to Lower MS Relapse Risk for Children
A study suggests that enough daily summer sun exposure in infancy and during pregnancy may be linked to a lower relapse risk in children diagnosed with multiple sclerosis MS.
A study suggests that enough daily summer sun exposure in infancy and during pregnancy may be linked to a lower relapse risk in children diagnosed with multiple sclerosis MS.
A large-scale study of military veterans suggests a possible link between hearing loss and increased risk of Parkinson’s disease.
People with higher levels of metals found in their blood and urine may be more likely to be diagnosed with—and die from—ALS, a new study suggests.
The PSS Referral Tool uses red, green, and yellow classification levels to help rehab professionals prioritize patients at risk for post-stroke spasticity.
Read MoreThe study will explore the use of novel digital biomarkers to monitor disease, with the aim of providing greater objectivity in multiple sclerosis assessment.
Read MoreStony Brook researchers are using computer and AI technologies to create a Caregiving Robot Assistant (CART) for ALS patients and their caregivers.
Read MoreHop On a Cure has a new financial contribution toward research at Massachusetts General Hospital Department of Neurology’s Sean M. Healey & AMG Center for ALS.
Read MoreThis program will provide patients with access to Neurologic Music Therapy, using music and evidenced-based interventions to improve areas of movement, language, and cognition.
Read MoreThis research aims to monitor cognitive workload using a wearable cyber-physical system with a novel sensor to improve concussion recovery.
Read MoreWomen are three times more likely than men to get diagnosed with multiple sclerosis. Now, rates of MS are on the rise among Black women.
Read MoreA preliminary study investigates if people who have headaches after a concussion have higher levels of iron in areas of the brain, a sign of injury to brain cells.
Read MoreNSCF will send human brain organoids derived from patients with two different types of degenerative brain diseases—Parkinson’s and PPMS—to the orbiting laboratory.
Read MoreThe company says the clearance is supported by safety and effectiveness data of the exoskeleton in patients with spinal cord injuries at levels T5 to L5 and has been evaluated in more than 500 patients.
Read MoreThe company’s investment stands to strengthen innovation and the supply chain for its products, beginning with brain-computer interfaces such as a neuroprosthesis to restore motor signaling for individuals with motor impairment.
Read MoreA new study uncovers the dose-response relationship between smoking and risk of amyotrophic lateral sclerosis.
Read MoreWith the company’s upgraded ISO13485:2016 quality certification, it aims to bring its Class II products that restore function and improve mobility to new markets.
Read MoreThree centers are involved in the recruiting and onboarding for a clinical study aimed at leveraging Real-World Data to enhance Parkinson’s disease treatment.
Read MoreResearchers have developed a robotic system for collecting precise data on how people recovering from stroke use their arms spontaneously.
Read More